Who owns Deciphera Pharmaceuticals Inc?
- CUSIP Number: 24344t101
Tip: Access positions for across all investors
Analyze quarterly positions in Deciphera Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Deciphera Pharmaceuticals stock
Who bought or sold Deciphera Pharmaceuticals Inc this quarter?
There are no current stakeholders of Deciphera Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Deciphera Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 6.0M | $94M |
| Armistice Capital | Mar 2024 | 5.9M | $93M |
| Vanguard Group | Mar 2024 | 4.6M | $72M |
| State Street Corporation | Mar 2024 | 3.1M | $49M |
| Goldman Sachs Group | Mar 2024 | 2.0M | $31M |
| Morgan Stanley | Mar 2024 | 1.5M | $24M |
| Nuveen Asset Management | Mar 2024 | 1.4M | $22M |
| Leucadia National Corporation | Mar 2024 | 823k | $13M |
| Parkman Healthcare Partners | Mar 2024 | 729k | $12M |
| Northern Trust | Mar 2024 | 516k | $8.1M |
| PanAgora Asset Management | Mar 2024 | 417k | $6.6M |
| Two Sigma Advisers | Mar 2024 | 401k | $6.3M |
| Two Sigma Investments | Mar 2024 | 312k | $4.9M |
| Qube Research & Technologies | Mar 2024 | 242k | $3.8M |
| Rafferty Asset Management | Mar 2024 | 218k | $3.4M |
| Ghost Tree Capital | Mar 2024 | 177k | $2.8M |
| ExodusPoint Capital Management | Mar 2024 | 161k | $2.5M |
| Martingale Asset Management | Mar 2024 | 70k | $1.1M |
| Thrivent Financial for Lutherans | Mar 2024 | 70k | $1.1M |
| ALPS Advisors | Mar 2024 | 57k | $897k |
| Alliancebernstein | Mar 2024 | 54k | $849k |
| DekaBank Deutsche Girozentrale | Jun 2024 | 50k | $759k |